TLR signaling pathways

Seminars in Immunology

Volumn 16, Issue 1, 2004, Pages 3-9

  Takeda, Kiyoshi ^a   Akira, Shizuo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Innate immunity; Signal transduction; TIR domain; TLR

Indexed keywords

ADAPTOR PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; ISOENZYME; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN SERINE THREONINE KINASE; TIR DOMAIN CONTAINING ADAPTOR INDUCING BETA INTERFERON; TIR DOMAIN CONTAINING ADAPTOR PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

IMMUNE RESPONSE; IMMUNITY; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR SENSITIVITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0742324860     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2003.10.003     Document Type: Article

References (53)

1. Hashimoto C., Hudson K.L., Anderson K.V. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell. 52:1988;269-279.
2. Lemaitre B., Nicolas E., Michaut L., Reichhart J.-M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
3. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
4. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutation in Tlr4 gene. Science. 282:1998;2085-2088.
5. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U.S.A. 95:1998;588-593.
6. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y.et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
7. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M.et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 401:1999;811-815.
8. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
9. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
10. Takeuchi O., Takeda K., Hoshino K., Adachi O., Ogawa T., Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 12:2000;113-117.
11. Takeuchi O., Kaufmann A., Grote K., Kawai T., Hoshino K., Morr M.et al. Cutting edge: preferentially the R-stereoisomer of the Mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164:2000;554-557.
12. Hacker H., Vabulas R.M., Takeuchi O., Hoshino K., Akira S., Wagner H. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192:2000;595-600.
13. Schnare M., Holt A.C., Takeda K., Akira S., Medzhitov R. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr. Biol. 10:2000;1139-1142.
14. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo S., Hoshino K.et al. Small antiviral compounds activate immune cells via TLR7 MyD88-dependent signalling pathway. Nat. Immunol. 3:2002;196-200.
15. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R.et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor-5. Nature. 410:2001;1099-1103.
16. Janssens S., Burns K., Tschopp J., Beyaert R. Regulation of interleukin-1 and lipopolysaccharide-induced NF-κB activation by alternative splicing of MyD88. Curr. Biol. 12:2002;467-471.
17. Burns K., Janssens S., Brissoni B., Olivos N., Beyaert R., Tschopp J. Inhibition of IL-1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197:2003;263-268.
18. Cao Z., Henzel W.J., Gao X. Irak: a kinase associated with the interleukin-1 receptor. Science. 271:1996;1128-1131.
19. Janssens S., Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell. 11:2003;293-302.
20. Swantek J.L., Tsen M.F., Cobb M.H., Thomas J.A. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164:2000;4301-4306.
21. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T., Mirtsos C.et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 416:2002;750-756.
22. Li S., Strelow A., Fontana E.J., Wesche H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. U.S.A. 99:2002;5567-5572.
23. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A. Jr., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:2002;191-202.
24. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev. 12:1998;2821-2830.
25. Lomaga M.A., Yeh W.C., Sarosi I., Duncan G.S., Furlonger C., Ho A.et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1999;1015-1024.
26. Naito A., Azuma S., Tanaka S., Miyazaki T., Takaki S., Takatsu K.et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 4:1999;353-362.
27. Deng L., Wang C., Spencer E., Yang L., Braun A., You J.et al. Activation of the IÉ ≫ B kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 103:2000;351-361.
28. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J.-I., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351.
29. Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B.et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2:2000;346-351.
30. Bulut Y., Faure E., Thomas L., Equils O., Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167:2002;987-994.
31. Zhang G., Ghosh S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 77:2002;7059-7065.
32. Yu K.Y., Kwon H.J., Norman D.A., Vig E., Goebl M.G., Harrington M.A. Cutting edge: mouse Pellino-2 modulates IL-1 and lipopolysaccharide signaling. J. Immunol. 169:2002;4075-4078.
33. Jiang Z., Johnson H.J., Nie H., Qin J., Bird T.A., Li X. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J. Biol. Chem. 278:2003;10952-10956.
34. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S.et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IRF-3 and the expression of a subset of LPS-inducible genes. J. Immunol. 167:2001;5887-5894.
35. Doyle S.E., Vaidya S.A., O'Connell R., Dadgostar H., Dempsey P.W., Wu T.-T.et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17:2002;251-263.
36. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S.et al. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β- dependent gene expression in macrophages. Nat. Immunol. 3:2002;392-398.
37. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., Akira S. Differential involvement of IFN-β in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14:2002;1225-1231.
38. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 413:2001;732-738.
39. Weaver B.K., Kumar K.P., Reich N.C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18:1998;1359-1368.
40. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1998;1087-1095.
41. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K.et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity. 13:2000;539-548.
42. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science. 300:2003;1148-1151.
43. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T.et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:2003;491-496.
44. Bonnard M., Mirtsos C., Suzuki S., Graham K., Huang J., Ng M.et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription. EMBO J. 19:2000;4976-4985.
45. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:2001;835-841.
46. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C., Mansell A.S., Brady G.et al. Mal (MyD88-adaptor-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
47. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K.et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169:2002;6668-6672.
48. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4:2003;161-167.
49. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 420:2002;329-333.
50. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T.et al. Essential role of TIRAP/Mal for activation of the signaling cascade shared by TLR2 and TLR4. Nature. 420:2002;324-329.
51. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H.et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science. 301:2003;640-643.
52. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O.et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424:2003;743-748.
53. Bin L.H., Xu L.G., Shu H.B. TIRP: a novel TIR domain-containing adapter protein involved in Toll/interleukin-1 receptor signaling. J. Biol. Chem. 278:2003;24526-24532.